WorksheetsBlood and Tissue Flagellates - Leishmania spp.
Total questions: 44
Worksheet time: 25mins
Leishmania are _____ protozoans
Haploid
Diploid
Triploid
Android
Which does not belong to the Old World (epidemiological division)
L. tropica
L. aethiopica
L. major
L. mexicana
Which of the following belongs to New World (Epidemiological division)
L. mexicana
L. amazonensis
L. guyanensis
L. braziliensis
L. chagasi
Insect Vector
Old world: ____ ; New world: _____
Phlebotomus; Lutzomyia
Lutzomyia; Phlebotomus
Phlebotomus; Longipalpis
Anopheles, Longipalpis
Reservoir host
Urban only
Cat
Rodent
Dog
Cockroach
Reservoir host
Urban and Rural
Cats
Rodents
Dogs
Cockroach
Ovoid/rounded bodies
Live intracellularly in monocytes, PMNs, endothelial cells
Large nucleus
Amaszygotes
Axonemes
Amasbigotes
Amastigotes
It arises from kinetoplast and extends to anterior tip
Amaszygote
Axoneme
Amasbigote
Amastigote
Single free flagellum
Found in hindgut, midgut, proboscis of insect vectors
Amaszygotes
Amasbigotes
Amastigotes
Promastigotes
1st & 2nd step of life cycle
(1) Infective (a) in proboscis of sandfly injected into the host's skin during feeding and (2) invades the cells of reticuloendothelial system
3rd step
(3) It then transform into amastigotes & multiply by (a)
4th step
When parasitized cell ruptures, amastigotes released will infect new cells or taken up by sandflies during feeding, where they transform into promastigotes in the gut, multiply by binary fission and migrate to foregut
True
False
Mode of Transmission
Congenitally
Blood transfusion
Bite wound contamination
Direct contact with contaminated specimens
Immune response of the host against the infection
Leishmania-specific Th1-type CD4+ T-cells
Macrophages
Cytokines
All of the above
Factors that may affect the outcome of the infection
Genetics
Nutritional Status
Environmental status
Financial status
Most common form of Leishmaniasis
(Caused by L. tropica, L. major, L. mexicana)
Mucocutaneous Leishmaniasis
Cutaneous Leishmaniasis
Diffuse Cutaneous Leishmaniasis
Visceral Leishmaniasis
An erythematous papule/nodule at inoculation site with raised edges, central crater, and forms a violacenous ulcer as it enlarges in size
Occidental button
Accidental button
Red button
Oriental button
Incubation period of cutaneous leishmaniasis
2 weeks to several months
2 days to several weeks
2 hours to several days
2 days to several months
• Aka anergic/lepromatous leishmaniasis
• Localized, non-ulcerating papule
• Developing numerous diffuse satellite lesions that affect the face and extremities
• Initially diagnosed as lepromatous leprosy
Diffuse Cutaneous Leishmaniasis
Cutaneous Leishmaniasis
Visceral Leishmaniasis
Mucocutaneous Leishmaniasis
• Develops in 2 to 5% of persons infected with L. braziliensis
• Contiguous spread of cutaneous leishmaniasis (L. tropica)
• Involve mucous membranes of nasal & oral cavities that progress to the pharynx and larynx
Diffuse Cutaneous Leishmaniasis
Visceral Leishmaniasis
Cutaneous Leishmaniasis
Mucocutaneous Leishmaniasis
• Lesions usually manifest with few parasites
• Systemic Th1 response is strong
• Increased levels of peripheral mononuclear cells in blood
Diffuse Cutaneous Leishmaniasis
Visceral Leishmaniasis
Mucocutaneous Leishmaniasis
Cutaneous Leishmaniasis
• AKA kala azar
• Disseminated parasitosis by L. donovani complex (L. donovani, L. chagasi & L. infantum)
• Manifestations stems from parasite spread into bone marrow, spleen, liver
Visceral Leishmaniasis
Diffuse Cutaneous Leishmaniasis
Cutaneous Leishmaniasis
Mucocutaneous Leishmaniasis
Regarding VL
• x2 daily fever spikes (double quotidian)
• with accompanying chills may be present
• may be mistaken for malaria
Subacute phase
Acute phase
Chronic phase
None of the above
Leishmania–specific Th1 response is usually (a) (low or high) in VL
• Sequela of visceral leishmaniasis
• Endemic area
• Cutaneous eruption
• Results in: hypopigmented macules, malar erythema, nodule, ulceration
• Usually manifest a few months to several years after treatment
Pre-kala azar dermal leishmaniasis
kala azar dermal leishmaniasis
Post-kala azar dermal leishmaniasis
The microscopic demonstration of _________ confirms the diagnosis of leishmaniasis via lesions scrapings, aspirates, or biopsy (Giemsa and hematoxylin-eosin stains)
Proamastigotes
Amastigotes
Proamaszygotes
Amaszygotes
____________ are unreliable due to the difficulty of isolating the parasites
Microscopic diagnosis
Immunologic Assay
Direct agglutination
Cultures
• Used to detect exposure to the parasite
• Usually POSITIVE in cases of CL & MCL
• NEGATIVE in cases of DCL & kala azar
Leishmanin skin test
Montenegro skin test
Tuberculin skin test
Mama mo skin test
It demonstrated high sensitivity and specificity for VL in certain immunocompetent patient populations (i.e. ELISA & Rk38 antigen dipstick test)
Cultures
Direct agglutination
Immunologic Assay
Microscopic Diagnostics
It is used to identify the species of Leishmania
Direct agglutination
Urine antigen assay
Flow cytometry
Molecular diagnostic modalites
(i.e. PCR & RFLP analysis)
Intradermal application of a solution containing antigenic preparation of promastigote forms of Leishmania.
Results are evaluated w/in 48 hours w/ ballpen (+ if papule is equal or greater than 5mm)
Leishmanin Skin Test
Montenegro Skin Test
Tuberculin Skin Test
Both Leishmanin and Montenegro
Skin Test
Treatment used in areas where susceptibility is good due to their low cost
Amphotericin B
Topical paramomycin
Pentavalent antimonials
Miltefosine
Examples of antimonials used for leishmaniasis
Miltefidine
Sodium stibogluconate
N-methyl-glucamine/meglumine
Pentamidine
This treatment requires daily intramuscular or intravenous administration for 4 weeks, hospital confinement, and should only be done after consultation w/ an infectious disease expert
Amphotericin B
Topical paramomycin
AmBisome
Pentavalent antimonials
Treatment used in case of treatment failure with antimonials, or in areas where resistance is high
Amphotericin B (IV)
AmBisome
Miltefosine
Pentamidine
Lipid-based preparation of Amphotericin B which is higly effective, better tolerated, and is the overall cost-effective drug for CL & VL
(a)
Only oral drug currently given to VL patients
Pentamidine
Hexamidine
Miltefosine
Paramomycin
Another second line drug for cutaneous and
visceral leishmaniasis but limited use due to side effects and prone to drug resistance
Hexamidine
Miltefosine
Paramomycin
Pentamidine
Treatment for
Cutaneous Leishmaniasis
Topical amphotericin B
Topical paramomycin
Topical pentamidine
Topical miltefosine
Possible combination therapy/ies for leishmaniasis
Sodium stibogluconate plus paramomycin
Liposomal amphotericin B plus miltefosine
Liposomal amphotericin B plus sodium
stibogluconate
All of the above
Cutaneous leishmaniasis mostly occurs in
Afghanistan & Brazil
Iran & Peru
Saudi Arabia & Syria
All of the above
Mucocutaneous Leishmaniasis occurs in Bolivia, Brazil and Peru
True
False
Secret walang clue
Important opportunistic infection in AIDS patients and occurs in Bangladesh, Brazil, India, Nepal, and Sudan
Mucocutaneous Leishmaniasis
Diffuse Cutaneous Leishmaniasis
Cutaneous Leishmaniasis
Visceral Leishmaniasis
Prevention and Control
(Bonus: Click both kapag tapos na basahin)
1. Insect repellants containing DEET and permethrin
2. Insecticide-treated clothing
3. Fine-mesh bed nets
4. Fine mesh screens
5. Spraying of houses and buildings
6. Regulation of zoonotic transmissions
Tapos ko na pong basahin hehe tenkyu
Pramis tapos ko na basahin hehe
